With the second call, the GPF Vaccinology aims at identifying ongoing preclinical projects aiming to develop vaccine candidates at Institut Pasteur, including the International Network. The objective of the GPF call is to help these projects to move forward into clinical phases. Preclinical projects may be at the stage of 1) early studies necessary to achieve proof of principle of immunogenicity and efficacy of the vaccine candidate in vitro and/or in animal models or 2) advanced testing to fulfill regulatory requirements to enter clinical development.
For details see: GPF Vaccinology call 2_2015_Accelerating Preclinical Development
Application closed September 30, 2015.